Gray-market drug scheme leads to $20M forfeiture, 30 years in slammer

A Texas man was found to have laundered more than $40 million through a fake drug distributorship that bought drugs off the street and then sold them as new. (Pixabay)

A man who made tens of millions of dollars selling gray-market drugs in the U.S. has not only been sentenced to 30 years in federal prison, he is being made to pay a $700,000 tax bill.

Kenneth J. Coleman, 52, of Houston, Texas, was sentenced to 360 months for conspiracy and tax charges, after being convicted on nine counts that included conspiracy to commit money laundering and corporate tax evasion.

The government says Coleman laundered more than $41.5 million through a fake drug distribution business. In addition to prison time, he was ordered to forfeit $20.3 million and to pay $717,000 in restitution to the IRS.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

Coleman owned Acacia Pharma Distributors and Four Corner Suppliers, which purchased bottles of prescription medications from “illegitimate sources” and then sold them to a Utah-based distributor, which then sold them to pharmacies as new, the FDA reported. The company created fake pedigrees to disguise them.

A partner in the business, Marcus Weathersby, pleaded guilty and testified against Coleman. Weathersby was sentenced to just short of five years in prison.


Suggested Articles

As a key global ingredient supplier, problems in China can ripple worldwide as they have for Swiss CDMO Lonza.

What challenges continue to plague the pharmaceutical industry for almost a decade? Check out this remarkable innovation in glass science that may be the…

WuXi Biologics says its plant in Wuxi, China, has gotten the go-ahead from the FDA to make HIV drug Trogarzo for TaiMed Biologics.